Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| 1 |
Regeneron Pharmaceuticals
REGN
|
$884M |
| 2 |
JD.com
JD
|
$784M |
| 3 |
Dollar General
DG
|
$667M |
| 4 |
Monster Beverage
MNST
|
$324M |
| 5 |
Starbucks
SBUX
|
$249M |
Top Sells
| 1 |
Union Pacific
UNP
|
$611M |
| 2 |
Mondelez International
MDLZ
|
$554M |
| 3 |
Alibaba
BABA
|
$438M |
| 4 |
CELG
Celgene Corp
CELG
|
$408M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
$362M |
Sector Composition
| 1 | Healthcare | 21.02% |
| 2 | Consumer Discretionary | 16.05% |
| 3 | Technology | 13.06% |
| 4 | Communication Services | 12.46% |
| 5 | Financials | 9.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ISBC
451
DELISTED
Investors Bancorp, Inc.
ISBC
| $21.1M | 0.02% |
1,715,506
+70,217
| +4% | +$864K |
|
452
Bloomin' Brands
BLMN
$586M
| $21M | 0.02% |
985,119
+961,351
| +4,045% | +$20.5M |
|
453
Cheniere Energy
CQP
$25.9B
| $20.9M | 0.02% |
676,025
+11,192
| +2% | +$345K |
|
454
United Natural Foods
UNFI
$1.73B
| $20.2M | 0.02% |
316,876
+46,671
| +17% | +$2.97M |
|
455
National Storage Affiliates Trust
NSA
$2.52B
| $20.1M | 0.02% |
+1,617,348
| New | +$20.1M |
|
456
BioCryst Pharmaceuticals
BCRX
$1.71B
| $19.7M | 0.02% |
1,317,717
+344,618
| +35% | +$5.15M |
|
|
MKTO
457
DELISTED
MARKETO INC COM STK (DE)
MKTO
| $19.5M | 0.02% |
694,010
+90,770
| +15% | +$2.55M |
|
458
Sangamo Therapeutics
SGMO
$164M
| $19.2M | 0.02% |
1,731,499
+13,577
| +0.8% | +$151K |
|
|
BECN
459
DELISTED
Beacon Roofing Supply, Inc.
BECN
| $19.2M | 0.02% |
576,976
+130,954
| +29% | +$4.35M |
|
|
DBVT
460
DBV Technologies
DBVT
$243M
| $18.8M | 0.02% |
62,962
+91
| +0.1% | +$27.1K |
|
|
PKY
461
DELISTED
Parkway, Inc.
PKY
| $18.6M | 0.02% |
1,068,807
+159,435
| +18% | +$2.78M |
|
462
Agios Pharmaceuticals
AGIO
$2.14B
| $17.6M | 0.02% |
157,949
+1,272
| +0.8% | +$141K |
|
|
VSLR
463
DELISTED
VIVINT SOLAR, INC.
VSLR
| $17.2M | 0.02% |
1,415,607
| – | – |
|
|
SPNC
464
DELISTED
Spectranetics Corp
SPNC
| $17.1M | 0.02% |
741,754
-73,171
| -9% | -$1.68M |
|
465
Glaukos
GKOS
$5.28B
| $16.8M | 0.02% |
+580,630
| New | +$16.8M |
|
466
IMAX
IMAX
$1.66B
| $16.7M | 0.02% |
415,214
-101,443
| -20% | -$4.09M |
|
|
ZOES
467
DELISTED
Zoe's Kitchen, Inc.
ZOES
| $16.7M | 0.02% |
407,955
-11,022
| -3% | -$451K |
|
|
CIM
468
Chimera Investment
CIM
$1.19B
| $16.6M | 0.02% |
404,611
+19,863
| +5% | +$817K |
|
469
Xencor
XNCR
$596M
| $16.6M | 0.02% |
755,505
+4,997
| +0.7% | +$110K |
|
470
Seres Therapeutics
MCRB
$195M
| $16.2M | 0.01% |
+19,500
| New | +$16.2M |
|
471
Kinross Gold
KGC
$27.4B
| $16.1M | 0.01% |
6,947,373
+24,412
| +0.4% | +$56.6K |
|
472
Ocular Therapeutix
OCUL
$2.32B
| $16.1M | 0.01% |
766,279
+627,861
| +454% | +$13.2M |
|
473
ProQR Therapeutics
PRQR
$248M
| $16.1M | 0.01% |
966,433
+2,968
| +0.3% | +$49.5K |
|
|
AGTC
474
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $16M | 0.01% |
1,041,823
+6,601
| +0.6% | +$101K |
|
475
Varonis Systems
VRNS
$6.36B
| $15.7M | 0.01% |
2,132,652
+157,443
| +8% | +$1.16M |
|